CRP and infarction: High sensitivity C reactive protein (hs-CRP), an important inflammation biomarker, was found to be significantly increased in post-infarction subjects in relation to controls, for both smokers (0.87 ± 0.2 vs. 0.39 ± 0.05, p < 0.05) and non-smokers (0.86 ± 0.28 vs. 0.3 ± 0.05, p < 0.05).